Evaluation of patient dose and operator dose in swallowing CT studies performed with a 320-detector-row multislice CT scanner by Kobayashi Masanao et al.
Evaluation of patient dose and operator dose
in swallowing CT studies performed with a
320-detector-row multislice CT scanner













Title of article: 
Evaluation of Patient Dose and Operator Dose in Swallowing CT Studies Performed 
with a 320-Detector-Row Multislice CT Scanner 
 
Names: 
Masanao Kobayashi, MS1, Kichiro Koshida, PhD*2,Shoichi Suzuki, PhD*3 and Kazuhiro 
Katada, MD, PhD*4 
 
Complete addresses: 
*1 Department of Radiology, Fujita Health University Hospital, Toyoake, Japan 
*2 Kanazawa University, Graduate School of Medical Sciences, Division of Medical 
Sciences, Kanazawa, Japan 
*3 Graduate School of Health Sciences, Fujita Health University, Toyoake, Japan 
*4 Department of Radiology, Fujita Health University School of Medicine, Toyoake, 
Japan 
 
Present address, telephone and fax numbers, and e-mail 
 
Masanao Kobayashi 
Department of Radiology, Fujita Health University Hospital 








Recently, attempts to develop new types of swallowing function analysis with 
320-detector-row multislice CT (320-MDCT) have been reported. The present report 
addresses (1) patient exposure, (2) operator exposure, and (3) spatial dose distribution. 
For dose measurement, a human-body phantom in which 303 thermoluminescent 
dosimeter elements were inserted and a survey meter was used. The patient position 
was confirmed with a single-volume scan at a tube voltage of 120 kV, a tube current of 
10 mA, a rotation speed of 0.35 s/rot., a slice thickness of 0.5 mm, coverage of 160 mm, 
a scan field of view of 240 mm, a small focal spot size, and a gantry tilt angle of 22 
(volume CT dose index;CTDIvol displayed on the console: 0.8 mGy, dose-length 
product;DLP: 12.1 mGycm). The effective dose for the patient in swallowing CT  was 
3.9 mSv. The conversion factor for obtaining the effective dose was 0.0066 
mSv/mGycm. The effective dose for the operator was 0.002 mSv. In the operator 
exposure measurement, the ambient dose equivalent H*(10), that would be produced 
by an expanded and aligned radiation field at a depth 10 mm in the International 
Commission on Radiation Units and Measurements (ICRU) sphere, was 0.012 mSv. In 
this report, the safety of swallowing CT, which has become possible with the 
introduction of 320-MDCT, was evaluated by measurement of the exposure to the 
patient and operator.  
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Videofluoroscopy (VF) and videoendoscopy (VE) have typically been 
employed for the functional evaluation of swallowing. In particular, VF is less invasive 
than VE and has the advantage that the dynamics of swallowing can be observed in 
X-ray images. VF has therefore served as the basis for the establishment of functional 
analysis. Recently, attempts to develop new types of swallowing function analysis with 
use of 320-detector-row multislice CT have been reported [1,2]. The main advantages 
of swallowing CT (SCT) are that images can be observed in the axial direction and 
other directions that cannot be acquired by VF, morphologic evaluation is possible on 
3D images, and dynamic analysis can be performed with use of 4D images. It is also 
anticipated that the data obtained by SCT will prove useful for the evaluation of 
swallowing disorders and lead to the development of new rehabilitation techniques. 
When standard examination protocols have been established and the software programs 
required for functional analysis have been developed, it is expected that SCT will 
become a practical CT examination. 
However, the radiation dose is an important consideration in all examinations 
employing ionizing radiation. Proper risk-benefit analysis of this imaging technique 
requires accurate estimates of the patient and operator doses. Dose control for both 
patients and operators is essential in SCT if this new technology is to gain widespread 
acceptance. Simple analyses of exposure in VF and SCT have been presented in 
previous reports [1,2]. The results of these reports suggest that deterministic effects are 
unlikely in SCT, as in many other diagnostic examinations involving X-rays. However, 
the evaluation of SCT with regard to the assessment of swallowing function in certain 
clinical cases has just begun. It is expected that SCT will be employed for research and 
for diagnosis in various cases, and examination techniques and methods will undergo 
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further development accordingly. Dynamic CT often involves rather high doses, and 
careful dose control is therefore required. Conducting detailed dose control in a new 
type of examination from its early stages provides useful information for future studies 
on the examination method.  
The present report addresses the following points: (1) The exposure in SCT was 
reevaluated in detail for various tissues and organs. (2) In SCT, it is necessary to match 
the swallowing timing with the scan timing, and the operator remains in the scan room 
during the examination to give the patient instructions related to swallowing. It is 
therefore necessary also to control the exposure to the operator. The exposure to the 
operator due to scattered radiation was evaluated. (3) A reclining chair made of the 
same carbon material as the bed is used to support the patient in SCT examinations, and 
the gantry is tilted to the maximum tilt angle of 22. The spatial dose distribution in the 
scan room under these specific conditions has never been measured. For investigation 
of methods for reducing the exposure to the operator, measurements were obtained, and 
evaluation of the spatial dose distribution, was evaluated. 
 
2. Materials  and Methods 
2.1 Evaluation of patient exposure  
A multi-detector row CT scanner with 320 rows of detector elements 
(320-MDCT; Aquilion ONE, Toshiba Medical Systems, Otawara, Japan), which is 
capable of data acquisition at a slice thickness 0.5 mm with a coverage of 160 mm, was 
used in this study. The patient position was confirmed with a single-volume scan at a 
tube voltage of 120 kV, a tube current of 10 mA, a rotation speed of 0.35 s/rot., a slice 
thickness of 0.5 mm, coverage of 160 mm, a scan field of view of 240 mm, a small focal 
spot size, and a gantry tilt angle of 22 (volume CT dose index (CTDIvol) displayed on 
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the console: 0.8 mGy, dose-length product (DLP): 12.1 mGycm). For SCT, a dynamic 
scan was performed with scan conditions of 60 mA and 0.35 s/rot.  9 rotations, 3.15 
seconds total scan time (cumulative CTDIvol: 36.4 mGy, cumulative DLP: 581.7 
mGycm). These parameters are summarized in Table 1.  
A human-body phantom (Alderson Rando phantom) in which 303 
thermoluminescent dosemeter (TLD) elements (MSO-S, Kyokko, Japan) were inserted 
was placed on a reclining chair that was tilted to 45, and its position was adjusted so 
that the chin was pointing in the Z direction and the pharynx was at the same level as 
the center in the X direction (Fig.1a). The directions were defined as follows: X 
direction (lateral: left-right), Y direction (dorsoventral: anterior-posterior), and Z 
direction (craniocaudal: cranial-caudal). Figure 2 shows the placement of the TLD 
elements. After X-ray exposure, the amount of fluorescence (M) was measured for the 
TLD elements by use of a TLD reader (model 3000, Kyokko, Japan). For each TLD 
element, the dose in air (Dair) was calculated with use of a correction factor, f, obtained 
by calibration of the reading of a 6-cm3 thimble ionization chamber (10X5-6, Radcal 
Corporation, Monrovia, CA, USA) in free air and the reading of an ionization chamber 
dosimeter (9015, Radcal Corporation) in free air. The organ dose, D(Gy), was then 
calculated by multiplying of the air absorbed dose (Gy) by the ratio of the mass 
energy-absorption coefficient of air and that of each organ [3]. The equivalent dose, 
HT(Sv), was then calculated by multiplication of the organ dose by the radiation 
weighting factor (1.0) specified in the International Commission on Radiological 
Protection (ICRP) publication 103 [4]. The effective dose, E(Sv), was calculated by 




With regard to the remaining tissues and organs, evaluation was performed for 
the adrenal gland, gallbladder, heart, kidney, pancreas, prostate gland (for males), small 
intestine, spleen, and uterus (for females). The conversion factor (mSv/mGycm) to be 
used for conversion of the DLP to the effective dose was estimated based on the DLP 
displayed on the console and the measured effective dose. 
Dair = M  f [Gy] (1) 
D = Dair  (en/)soft tissue etc./(en/)air [Gy] (2) 
HT = D  1.0 [Sv] (3) 
E = WT  HT [Sv] (4) 
where Dair is the air absorbed dose, M is the fluorescence, f is a correction factor 
obtained by calibration, D is the organ dose, (en/) is the ratio of the mass 
energy-absorption coefficient, HT is the equivalent dose, WT is the weighting factor for 
each tissue or organ, and E is the effective dose. 
 
2.2 Evaluation of operator exposure 
For representing the CT operator, another human-body phantom in which the 
TLD elements were inserted was covered with a lead-free X-ray apron (Dream light, 
Leaktech, Japan; 0.25 mm Pb equivalent) and placed at a position 1.25 m away from 
the rotation center of the CT gantry in the Z direction and 0.75 m away in the X 
direction (Fig.3). Another human-body phantom (Alderson Rando phantom) was 
placed on the reclining chair as a scatterer (Fig.1b).A measurement was then performed 
at the position where the operator usually stands to give the patient instructions related 
to swallowing. The phantom height was set to 1.6 m, which is the height of the SCT 
operator at our facility (Fig.1c). We performed X-ray generation with the SCT scan 
protocol 30 times in order to measure scattered radiation. The operator dose was 
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evaluated in terms of the entrance surface dose, organ doses, and effective dose for a 
single X-ray exposure with the SCT scan protocol. 
 
2.3 Evaluation of spatial dose distribution 
We used ion chamber survey meter (ICS-323, Aloka, Japan) to measure the 
spatial dose distribution. This survey meter was calibrated by a standard dosimetry 
laboratory. For the energy response test, the sensitivity is 1.0. The scan conditions used 
for patient position confirmation (120 kV, 10 mA, 0.35 s/rot.) were employed. After the 
background radiation level was measured, the survey meter was positioned with its face 
perpendicular to the rotation center, and the ambient dose equivalent H*(10), which is 
defined in International Commission on Radiation Units and Measurements (ICRU) 
Report 51 [5] as the dose equivalent that would be produced by an expanded and 
aligned radiation field at a depth of 10 mm in the ICRU sphere, was measured. A total 
of 118 measurement points were set at 50-cm intervals, with the reference position set 
to the CT gantry rotation center. At each measurement point, the H*(10) was measured 
at heights of 0 cm, +50 cm, and -50 cm, with the reference height (0 cm) set to the 
height of the CT gantry rotation center. A simplified diagram showing the scan room 
and the measurement points is shown in Figure 3. The spatial dose distribution in SCT 
was generated based on the measured values, and methods for reducing the operator 
exposure were investigated. 
 
3. Results 
3.1 Patient exposure 
Table 2 shows the organ doses and effective dose in SCT. The highest relative 
absorbed dose levels were measured for the thyroid gland (35.69 mGy), salivary gland 
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(34.91 mGy), and esophagus (27.62 mGy). Table 3 shows the absorbed dose to the lens 
of the eye in SCT as measured in the present study, as well as the absorbed dose to the 
lens of the eye in various types of CT examinations as reported in previous studies 
[6-10]. Compared with head and neck CT, the absorbed dose to the lens of the eye is 
lower in SCT. Table 4 shows the effective dose in SCT and the effective doses for neck 
CT and VF reported in numerous publications [1,11-18]. The effective dose in SCT is 
3.9 mSv, which is 1.0 mSv higher than that in typical neck CT and 3.5 mSv higher than 
that in VF. The conversion factor for obtaining the effective dose was calculated based 
on the DLP value displayed on the console (593.7 mGycm), and the result was 0.0066 
mSv/mGycm. 
 
3.2 Operator exposure 
Tables 5 and 6 show the organ doses and the effective dose to the operator in 
SCT. The highest relative absorbed dose levels were measured for the thyroid gland 
(0.016 mGy), esophagus (0.010 mGy), salivary gland (0.008 mGy), and lens of the eye 
(0.009 mGy), and the effective dose was 0.002 mSv. The absorbed dose to the skin on 
the chest was 0.002 mGy with the 2.5-mm Pb-equivalent lead-free X-ray apron and 
0.012 mGy without the apron. The absorbed dose to the gonads was 0.001 mGy with 
the lead-free X-ray apron and 0.010 mGy without the apron. These results confirmed 
the effectiveness of the X-ray protection provided by the lead-free X-ray apron. 
 
3.3 Spatial dose distribution 
Figure 4 shows the spatial dose distribution in SCT. At position A (in front of 
the patient's head on the rear side of the gantry), H*(10) was high at a height +50 cm 
from the gantry rotation center and low at a height -50 cm from the gantry rotation 
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center. At position B (45 with respect to the Z axis), H*(10) was low at +50 cm and 
high at -50 cm. At position C (couch end on the front side of the gantry), H*(10) was 
high at +50 cm and low at -50 cm. At position D (diagonally opposite position B), 
H*(10) was also high at +50 cm and low at -50 cm, but the spread of scattered radiation 
was broader as compared with position C. At the operator exposure  measurement 
position, H*(10) at a height of 0 cm was 1.7 mSv/h. When this value was converted 
from the total mAs in SCT (245 mAs), the result was 0.012 mSv, which matches the 




The absorbed dose was higher for the thyroid gland, salivary gland, esophagus, 
and lens of the eye than for other organs. The thyroid gland is known to be more 
radiosensitive than are other endocrine organs. However, the threshold dose for 
hyperthyroidism is 25 Gy to 30 Gy, which is 800 times higher than the absorbed dose to 
the thyroid gland in SCT (35.69 mGy). It has been reported that an absorbed dose of 1 
Gy or less does not lead to a reduction in thyroid function. It is therefore unlikely that 
SCT can directly cause thyroid dysfunction [19]. In addition, because the threshold 
dose for early transient erythema and temporary epilation is 2 Gy to 3 Gy, deterministic 
effects are unlikely in SCT, where the maximum doses are approximately 100 times 
less than deterministic dose thresholds. This is also true for the salivary gland and 
esophagus. The threshold dose for deterministic effects on the lens of the eye has been 
estimated to be 0.5 Gy to 2 Gy for lens opacification and 2 Gy to 10 Gy for cataract 
formation [20]. These values are 25 times to 500 times higher than the absorbed dose to 
the lens of the eye in SCT (20.76 mGy); it is therefore unlikely that SCT can have 
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deterministic effects on the lens of the eye. However, ICRP draft ref 4844-6029-7736 
[21], entitled "Early and late effects of radiation in normal tissues and organs: threshold 
doses for tissue reactions and other non-cancer effects of radiation in a radiation 
protection context" suggests that the threshold doses for deterministic effects on the 
lens of the eye may be lower than the currently accepted values, and it discusses 
whether radiation injury to the lens of the eye is due to deterministic or stochastic 
effects. The exposure of the lens of the eye must be considered more carefully in the 
future. In SCT, unlike head and neck CT, primary radiation does not enter the lens of 
the eye, and the absorbed dose remains below the level that may cause radiation injuries. 
In these results, even if SCT was performed several times, the possibility that the 
radiation injuries would occur was low. The organ dose and the effective dose in that 
case will be computed from the relationship between the tube current-time product and 
the dose. Nevertheless, the exposure must be reduced as much as possible. 
The effective dose in SCT was found to be 3.9 mSv, which is higher than that in 
neck CT and VF. SCT is a detailed examination that combines both morphologic and 
functional evaluation. For functional evaluation, it is necessary to scan continuously 
during swallowing, and the effective dose is therefore unavoidably increased. However, 
the effective dose in SCT is only half that of body CT (chest CT: 5 mSv to 7 mSv, 
abdominal CT: 5 mSv to 7 mSv) [22], in which a wide anatomic range is scanned and 
the vital organs are exposed to high levels of primary radiation. It therefore cannot be 
said that the effective dose in SCT is particularly high. 
No dose limits are applied to medical exposure in order to avoid imposing 
excessively strict restrictions on clinical practice. Nevertheless, SCT should be 
performed only when it is clinically indicated. In SCT, swallowing function can be 
evaluated accurately and noninvasively based on axial images, 3D images, and 4D 
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images. In addition, it is expected that analyzing the SCT examination results obtained 
for large numbers of patients may lead to the development of new rehabilitation 
techniques. Although SCT is currently considered to be in the research phase, it has 
many advantages and is a valid clinical examination technique.  
As the next step, it is important to determine the optimal scan conditions for 
SCT. With regard to technical optimization, the patient should practice swallowing 
before the examination. This permits the operator to determine the timing of 
swallowing, making it possible to reduce the scan time. With regard to mechanical 
optimization, motion artifacts must be reduced. It is expected that the exposure can be 
reduced by adjustment of the scan conditions once motion artifacts in dynamic scams 
have been minimized. However, one problem in attempting to determine the optimal 
scan conditions is that there is no reference level that can serve as a target value for 
exposure reduction. Until SCT examinations performed at various facilities have been 
evaluated and dose evaluation results have been collected, we suggest using an 
effective dose of 3.9 mSv as a provisional target value for dose reduction. We also 
suggest a conversion factor of 0.0066 (mSv/mGycm) for converting the DLP to the 
effective dose in SCT for adults, referring to ICRP 102 [18]. This value is close to the 
conversion factor for the adult neck (0.0059) shown in Table A.2 of ICRP 102, which 
was cited in the report of Bongartz et al.[23]. A conversion factor of 0.0059 was 
calculated by use of the X-ray CT effective dose estimation software ImPACT 
provided by United Kingdom’s CT scanner evaluation center. This software employs 
national radiological protection board (NRPB)-SR250 (CT-DOSE) as providing the 
basic data. NRPB-SR250 incorporates the results of Monte Carlo simulations with use 
of typical X-ray CT scanners and the MIRD-5 mathematical human phantom. Because 
SCT is currently available only in 320-MDCT, the factor of 0.0066 mSv/mGycm, 
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which we suggest in the present report can be used for evaluation of the effective dose 
more accurately than the factor of 0.0059 mSv/mGycm which covers various types of 
CT scanners. 
The effective dose to the operator was found to be 0.002 mSv per examination, 
which is quite low. The absorbed dose was higher for the thyroid gland, esophagus, 
salivary gland, and lens of the eye, which were not protected by the lead-free X-ray 
apron. Thyroid collars and radiation glasses are effective means for protecting these 
organs. However, the patient may feel uncomfortable if the operator wears too much 
radiation protection. If the operator does not wear head and neck protection while 
remaining in the scan room in order to give the patient instructions related to 
swallowing, the exposure to the head and neck can be reduced by her standing at a 
position at 45 relative to the gantry rotation center (position B in Fig.3). If the operator 
stands on an elevated platform, a further reduction in exposure can be expected. The 
positions at the front of the gantry (C and D in Fig.3) are not suitable, because 
observing and instructing the patient are difficult and the effects of scattered radiation 
are greater at these positions. 
It has been confirmed in previous studies that 320-detector-row multislice CT is 
useful in various clinical applications, including whole-brain perfusion CT, coronary 
CT, and pediatric CT. In this report, SCT, which has become possible due to the 
introduction of 320-detector-row multislice CT scanners, was evaluated by measuring 
of the exposure to the patient and operator. It was confirmed that SCT is a dynamic 
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Table 1 Scan conditions for SCT 
Scan Positioning CT Swallowing CT 
Scan mode Volume scan Dynamic scan 
Tube voltage (kV)  120 120 
Tube current (mA) 10 60 
Rotation time (s/rot.) 0.35 0.35 (3.15 s) 
Slice thickness (mm) 0.5 0.5 
Beam width (mm) 160 160 
Field of view (mm) 240 240 
Focal spot size Small Small 
Tilt angle () 22 22 
Cumulative CTDIvol (mGy) 0.8 36.4 
















Table 2 Organ dose and effective dose in SCT 
Organ/tissue Organ dose (mGy) 
Lung  2.61 
Stomach  0.30 
Colon  0.04 
Bone marrow 0.03 
Breast  3.95 
Gonads  0.01 




Bone surface 0.06 
Skin 6.07 
Brain 10.03 
Salivary gland 34.91 
Remainder 0.08 












Table 3 Comparison of absorbed dose to the lens of the eye between SCT and 
other types of CT 
Examination Publication Lens dose 
(mGy) 
Swallowing CT   20.76 
Head CT    Abdeen (2010)6) 43.561.5 
 Jaffe (2010)7)  2550 
Neck CT Yamauchi-Kawaura (2009)8)  10.632.0 
Face CT Zammit-Maempel (2003)9)  35.1 
























Table 4 Comparison of effective dose between SCT and other modalities 
Examination Publication Effective dose 
(mSv) 
Swallowing CT   3.9 
Neck CT    Kharuzhyk (2011)12)  2.61.0 
 Hayton (2009)11)  2.42.8 
 Yamauchi-Kawaura (2009)8) 1.86.6 
Videofluoroscopy  Wise (2004)13) 6.9 
 Iwai (2011)14) 0.12 
 Fujii (2011)1) 1.05 
 Chau (2009)15) 0.260.31  
 Zammit-Maempel (2007)16) 0.2  
 Wright (1998)17) 0.40  

















Table 5 Organ dose and effective dose to the operator in SCT 
Organ/tissue Organ dose (mGy) 
Lung  0.002 
Stomach  0.002 
Colon  0.002 
Bone marrow 0.001 
Breast  0.002 
Gonads  0.001 




Bone surface 0.001 
Skin 0.004 
Brain 0.002 
Salivary gland 0.008 
Remainder 0.001 












Table 6 Effectiveness of the lead-free X-ray apron and dose to the lens of the eye 
in SCT 
Organ/tissue Organ dose (mGy) 
Breast (+2.5 mmPb) 0.002 
Breast (2.5 mmPb) 0.012 
Gonads (+2.5 mmPb) 0.001 
Gonads (2.5 mmPb) 0.010 


























Fig.1 Setup for dose measurement in SCT. a: Measurement of patient dose, b and c: 






























































Fig.4 Spatial dose distribution in SCT. a: At height +50 cm from the gantry rotation 
center, b: At the height of the gantry rotation center, c: At height -50 cm from the gantry 
rotation center. 
 
 
 
